These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33529620)

  • 1. Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
    Elkholey K; Papadimitriou L; Butler J; Thadani U; Stavrakis S
    Am J Cardiol; 2021 May; 146():36-47. PubMed ID: 33529620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.
    Shah SJ; Heitner JF; Sweitzer NK; Anand IS; Kim HY; Harty B; Boineau R; Clausell N; Desai AS; Diaz R; Fleg JL; Gordeev I; Lewis EF; Markov V; O'Meara E; Kobulia B; Shaburishvili T; Solomon SD; Pitt B; Pfeffer MA; Li R
    Circ Heart Fail; 2013 Mar; 6(2):184-92. PubMed ID: 23258572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.
    Solomon SD; Claggett B; Lewis EF; Desai A; Anand I; Sweitzer NK; O'Meara E; Shah SJ; McKinlay S; Fleg JL; Sopko G; Pitt B; Pfeffer MA;
    Eur Heart J; 2016 Feb; 37(5):455-62. PubMed ID: 26374849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction.
    Kurgansky KE; Parker R; Djousse L; Gagnon DR; Joseph J
    J Am Heart Assoc; 2024 Jul; 13(14):e032231. PubMed ID: 38979805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.).
    Inampudi C; Parvataneni S; Morgan CJ; Deedwania P; Fonarow GC; Sanders PW; Prabhu SD; Butler J; Forman DE; Aronow WS; Allman RM; Ahmed A
    Am J Cardiol; 2014 Jul; 114(1):79-82. PubMed ID: 24846806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT.
    Szabo B; Benson L; Savarese G; Hage C; Fudim M; Devore A; Pitt B; Lund LH
    Am Heart J; 2024 May; 271():136-147. PubMed ID: 38412897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction.
    Caughey MC; Vaduganathan M; Arora S; Qamar A; Mentz RJ; Chang PP; Yancy CW; Russell SD; Shah SJ; Rosamond WD; Pandey A
    J Am Geriatr Soc; 2021 May; 69(5):1309-1318. PubMed ID: 33401338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of spironolactone/ARB on cardiovascular endpoints in heart failure patients with preserved ejection.
    Liu X; Wang Y; Yiu K; Zhang Y; Wang J
    Eur J Intern Med; 2024 Apr; ():. PubMed ID: 38637197
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.
    Ferreira JP; Verdonschot J; Wang P; Pizard A; Collier T; Ahmed FZ; Brunner-La-Rocca HP; Clark AL; Cosmi F; Cuthbert J; Díez J; Edelmann F; Girerd N; González A; Grojean S; Hazebroek M; Khan J; Latini R; Mamas MA; Mariottoni B; Mujaj B; Pellicori P; Petutschnigg J; Pieske B; Rossignol P; Rouet P; Staessen JA; Cleland JGF; Heymans S; Zannad F;
    JACC Heart Fail; 2021 Apr; 9(4):268-277. PubMed ID: 33549556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spironolactone on diastolic function in haemodialysis patients.
    Hauser T; Dornberger V; Malzahn U; Grebe SJ; Liu D; Störk S; Nauck M; Friedrich N; Dörr M; Wanner C; Krane V; Hammer F; ;
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):1927-1936. PubMed ID: 33544240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Nouraei H; Rabkin SW
    Int J Cardiol; 2021 May; 331():138-143. PubMed ID: 33529665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
    Ferreira JP; Claggett BL; Liu J; Desai AS; Pfeffer MA; Anand IS; van Veldhuisen DJ; Kober L; Cleland JGF; Rouleau JL; Packer M; Zile MR; Shi VC; Lefkowitz MP; Shah SJ; Vardeny O; Zannad F; Solomon SD; McMurray JJV
    Eur J Heart Fail; 2021 May; 23(5):776-784. PubMed ID: 33609066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial.
    Nassif ME; Qintar M; Windsor SL; Jermyn R; Shavelle DM; Tang F; Lamba S; Bhatt K; Brush J; Civitello A; Gordon R; Jonsson O; Lampert B; Pelzel J; Kosiborod MN
    Circulation; 2021 Apr; 143(17):1673-1686. PubMed ID: 33550815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel ATG16L1 mutations in a patient with acute myocardial infarction and coronary artery ectasia: A case report.
    Han F; Yan B
    Medicine (Baltimore); 2021 Jan; 100(4):e24497. PubMed ID: 33530273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    Beldhuis IE; Myhre PL; Bristow M; Claggett B; Damman K; Fang JC; Fleg JL; McKinlay S; Lewis EF; O'Meara E; Pitt B; Shah SJ; Vardeny O; Voors AA; Pfeffer MA; Solomon SD; Desai AS
    J Am Coll Cardiol; 2021 Mar; 77(9):1211-1221. PubMed ID: 33663739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital chloride diarrhea in patient with SLC26A2 mutation - analysis of the clinical phenotype and differential diagnosis.
    Sun M; Tao N; Liu X; Yang Y; Su Y; Xu F
    Pediatr Endocrinol Diabetes Metab; 2021; 27(1):51-56. PubMed ID: 33599438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous thrombosis of a vein of Galen malformation associated with acute sinusitis: a case report.
    Pulido LF; Murcia Salazar D; Gómez Amarillo D; Useche JN; Ghotme KA
    Childs Nerv Syst; 2021 Oct; 37(10):3271-3276. PubMed ID: 33595709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 49-Year-Old Man With Postcoital Hemoptysis.
    O'Corragain OA; Gupta R
    Chest; 2021 Feb; 159(2):e81-e85. PubMed ID: 33563459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial on the antihypertensive treatment effect of a quadruple single-pill combination.
    Hu LX; Wang D; Liu HL; Zhang QT; Sun DS; Zhang L; Chen X; Chang GL; Wang JG
    J Clin Hypertens (Greenwich); 2021 Apr; 23(4):815-822. PubMed ID: 33548084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients.
    Kovacevic KD; Greisenegger S; Langer A; Gelbenegger G; Buchtele N; Pabinger I; Petroczi K; Zhu S; Gilbert JC; Jilma B
    Sci Rep; 2021 Feb; 11(1):3092. PubMed ID: 33542410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.